Leadership Overview
Grupo NC has 6 executives leading key functions including strategy, holding management, technology, operations, and financial oversight.
Focused on delivering innovative healthcare solutions across South America and Asia, Grupo NC prioritizes sustainable development and excellence in pharmaceutical manufacturing to ensure a positive impact on global health markets.
Focused on delivering innovative healthcare solutions across South America and Asia, Grupo NC prioritizes sustainable development and excellence in pharmaceutical manufacturing to ensure a positive impact on global health markets.
Leadership Roles at Grupo NC
Luciane Desiato - Secretária Executiva Trilingue Chief Executive Officer
Luciane Desiato, the Secretária Executiva Trilingue Chief Executive Officer at Grupo NC, directs high-level corporate strategy and cross-border communication initiatives. Managing complex international relations, the Chief Executive Officer ensures seamless alignment between regional pharmaceutical manufacturing units and global partners. This leadership role involves optimizing organizational workflows to support the expansion into Asian markets while maintaining rigorous quality standards. By facilitating communication across diverse linguistic and cultural landscapes, Luciane Desiato strengthens the competitive position of the company within the South American healthcare sector. The Chief Executive Officer drives efficiency by integrating advanced administrative protocols with core business objectives. Through meticulous oversight of executive operations, the Chief Executive Officer fosters a culture of precision and accountability. Ultimately, the Chief Executive Officer secures the long-term viability of the organization by bridging internal operational needs with external market demands.
Thiago Tavares - Chief Executive Officer Holding
Thiago Tavares, the Chief Executive Officer Holding at Grupo NC, architects the overarching investment strategy and portfolio management for the entire pharmaceutical group. Overseeing the integration of various business units, the Chief Executive Officer Holding ensures that the B2B and B2C models remain synchronized with long-term growth targets. This leadership role involves evaluating market opportunities across Brazil and beyond to maximize shareholder value and operational synergy. By directing capital allocation toward innovative healthcare solutions, Thiago Tavares strengthens the market presence of the organization. The Chief Executive Officer Holding maintains a focus on sustainable development, ensuring that all subsidiary activities align with the core mission of the company. Through strategic governance and rigorous performance monitoring, the Chief Executive Officer Holding drives the group toward sustained profitability. Ultimately, the Chief Executive Officer Holding secures the stability and future trajectory of the entire enterprise.
Tatiana Fontes - Chief Financial Officer, At Grupo Nc Farma & Ems
Tatiana Fontes, the Chief Financial Officer, At Grupo Nc Farma & Ems at Grupo NC, directs the financial planning, budgeting, and fiscal reporting for the core pharmaceutical divisions. Overseeing the allocation of resources for research and development, the Chief Financial Officer, At Grupo Nc Farma & Ems ensures that financial health supports the innovation mission of the company. This leadership role involves managing complex tax structures and capital investments across the Brazilian market. By providing rigorous financial analysis, Tatiana Fontes enables informed decision-making regarding market expansion and product portfolio diversification. The Chief Financial Officer, At Grupo Nc Farma & Ems maintains strict oversight of cash flow and profitability metrics to ensure long-term stability. Through the management of financial risk and the optimization of revenue streams, the Chief Financial Officer, At Grupo Nc Farma & Ems drives the fiscal performance of the organization. Ultimately, the Chief Financial Officer, At Grupo Nc Farma & Ems secures the financial integrity of the group.
Nicole Da Gama - Chief Financial Officer, Assistente Executiva DE Diretoria
Nicole Da Gama, the Chief Financial Officer, Assistente Executiva DE Diretoria at Grupo NC, directs the administrative financial governance and executive support functions for the board of directors. Overseeing the preparation of financial disclosures and corporate governance reports, the Chief Financial Officer, Assistente Executiva DE Diretoria ensures transparency and compliance with regulatory requirements. This leadership role involves managing the interface between financial operations and executive decision-making processes. By coordinating high-level administrative tasks with fiscal oversight, Nicole Da Gama facilitates efficient communication and strategic alignment across the leadership team. The Chief Financial Officer, Assistente Executiva DE Diretoria monitors the financial impact of corporate policies to ensure consistency with the broader goals of the company. Through the integration of administrative precision and financial management, the Chief Financial Officer, Assistente Executiva DE Diretoria drives organizational effectiveness. Ultimately, the Chief Financial Officer, Assistente Executiva DE Diretoria secures the operational and financial alignment of the executive office.
Danieli Favero Moralez - Chief Operating Officer
Danieli Favero Moralez, the Chief Operating Officer at Grupo NC, directs the daily manufacturing and retail operations across all Brazilian facilities. Overseeing the end-to-end production lifecycle, the Chief Operating Officer ensures that pharmaceutical output meets the highest standards of quality and regulatory compliance. This leadership role involves streamlining logistics and distribution networks to support the dual B2B and B2C business model. By optimizing internal processes, Danieli Favero Moralez enhances operational throughput and reduces waste in line with sustainability goals. The Chief Operating Officer coordinates with regional managers to ensure consistent service delivery throughout South America. Through the implementation of lean manufacturing principles, the Chief Operating Officer drives significant gains in productivity and cost-efficiency. Ultimately, the Chief Operating Officer secures the operational excellence required to maintain the status of the company as a leading pharmaceutical industry player.
Diego Neufert - Chief Technology Officer
Diego Neufert, the Chief Technology Officer at Grupo NC, directs the digital transformation and technological infrastructure supporting pharmaceutical manufacturing. Overseeing the implementation of advanced data analytics and automated production systems, the Chief Technology Officer ensures that the company maintains a competitive edge in healthcare innovation. This leadership role involves modernizing IT frameworks to support both B2B and B2C retail services across South American operations. By integrating cutting-edge software solutions, Diego Neufert optimizes supply chain visibility and operational efficiency. The Chief Technology Officer collaborates with other C-suite leaders to align technical capabilities with the broader corporate strategy of the company. Through the deployment of secure and scalable digital platforms, the Chief Technology Officer drives continuous improvement in product development cycles. Ultimately, the Chief Technology Officer secures the technological foundation necessary for the long-term success and market leadership of the organization.
Explore Leadership Teams in Manufacturing
PiSA Farmacéutica is a socially responsible pharmaceutical company based in Mexico, specializing in the production of over 1,500 brands of medications across 17 specialty lines and 14 production plants. With a workforce of around 30,000 employees, the company emphasizes quality, integrity, and transparency in its operations. PiSA also engages in pharmacovigilance and technovigilance to ensure the safety and efficacy of its products. Their intended clients include hospitals and healthcare providers, reflecting their commitment to improving health outcomes.
Company Leadership AT
CR
YP
AJ
Founded in 1891 and headquartered in Rahway, NJ, Merck & Co., Inc. is a global healthcare company delivering innovative solutions through prescription medicines, biologic therapies, vaccines, and animal health products.
Company Leadership DS

BF
Founded and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership CO
Amrutanjan Health Care Ltd specializes in pain and congestion management products, including aromatic balms, roll-ons, and sprays. Founded in 1893, the company is dedicated to enhancing people's well-being by combining natural extracts with scientific research to create effective, side-effect-free solutions. Their product range caters to various needs, including headache relief, body pain management, and women's hygiene. Amrutanjan aims to serve a global consumer base while maintaining a commitment to sustainability and social responsibility.
Company Leadership MB
SN
JC